Herein, we report a simple and rational approach to the design of a targeted therapy ( i.e. , complex 1 ) whose mechanism of action involves targeting a single cancer relevant pathway via two independent mechanisms.
No takes yet. Share an insight, caveat, or question.
McCall et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: